Skip to content
Back to Resources

Machine Learning Models can Quantify CD8 positivity in Melanoma Clinical Trial Samples

The presence of CD8+ T cells in the tumor microenvironment is associated with response to immunotherapy and can inform patient treatment decisions1-3. However, characterization of immune cells in the tumor microenvironment is subject to challenges of manual scoring and interpathologist scoring variability.

To support the quantification and scoring of CD8+ T cells, PathAI has developed machine learning (ML)-based models that can identify and quantify CD8+ lymphocytes within the stroma and parenchyma regions of melanoma and other tumor types. Here, we focus on the ML model for melanoma showing recent results for ML-based identification and quantification of CD8+ lymphocytes and concordance with manual pathologic assessment in data derived from multiple clinical trials. Glass et al.
Get In Touch

Get In Touch

PathAI Media

Company Contact

Liz Storti

Chief People Officer

elizabeth.storti@pathai.com

Media Contact

Daniel Donato

LifeSci Communications

ddonato@lifescicomms.com

516-474-0554